Anat Hakim
Secretary, Executive VP & General Counsel |
Andy Vicari
Senior Director & US Brand Leader-Insulins |
Carole Ho
Executive VP & President-Lilly Neuroscience |
Carolyn R. Bertozzi
Director |
Daniel M. Skovronsky
Chief Scientific & Product Officer |
David A. Ricks
Chairman, President & Chief Executive Officer |
David Hyman
Chief Medical Officer |
Diogo Rau
Chief Information & Digital Officer, Executive VP |
Donald A. Zakrowski
Chief Accounting Officer & Senior VP-Finance |
Edgardo Hernandez
President-Manufacturing Operations & Senior VP |
Eric Dozier
Chief People Officer & Executive Vice President |
Ilya Yuffa
Executive VP- Global Customer Capabilities |
Jacob S. van Naarden
President-Lilly Oncology & Executive VP |
Jamere Jackson
Independent Director |
Jennifer Oleksiw
Global Chief Customer Officer & Vice President |
Jon Erik Fyrwald
Independent Director |
Jon R. Moeller
Independent Director |
Juan Ricardo Luciano
Lead Independent Director |
Katherine Baicker
Independent Director |
Kim Macko
Head-Global Brand Development |
Kimberly H. Johnson
Independent Director |
Laura A. Lane
Vice President |
Lucas E. Montarce
Chief Financial Officer & Executive Vice President |
Mark Genovese
Senior Vice President-Immunology Development |
Mary Lynne Hedley
Independent Director |
Melissa Seymour
Executive Vice President-Global Quality |
Michael Czapar
Senior Vice President-Investor Relations |
Nathaniel R. Miles
Vice President-Strategic Initiatives |
Patrik Jonsson
Executive VP & President-Lilly International |
Ralph Alvarez
Independent Director |
Robert Conley
Development Leader-Neuroscience |
Robert J. Heine
Vice President-Medical Affairs |
Ruth Gimeno
Vice President |
Thomas Fuchs
Chief Artificial Intelligence Officer & Senior VP |
William G. Kaelin
Independent Director |
